 Megan Curran
Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rheumatology | 8 | 2025 | 118 | 2.750 |
Why?
| | Education, Medical, Graduate | 11 | 2025 | 486 | 2.580 |
Why?
| | Fellowships and Scholarships | 11 | 2025 | 306 | 1.980 |
Why?
| | Clinical Competence | 13 | 2025 | 1118 | 1.890 |
Why?
| | Pediatrics | 12 | 2025 | 1101 | 1.510 |
Why?
| | Dermatomyositis | 6 | 2020 | 27 | 1.110 |
Why?
| | Lupus Erythematosus, Systemic | 6 | 2022 | 242 | 0.930 |
Why?
| | Sjogren's Syndrome | 2 | 2021 | 54 | 0.870 |
Why?
| | Education, Distance | 1 | 2020 | 50 | 0.620 |
Why?
| | Scleroderma, Systemic | 3 | 2025 | 122 | 0.550 |
Why?
| | Arthritis, Juvenile | 2 | 2020 | 56 | 0.520 |
Why?
| | Internship and Residency | 5 | 2025 | 1147 | 0.520 |
Why?
| | Hemorrhage | 1 | 2021 | 722 | 0.520 |
Why?
| | Educational Measurement | 1 | 2019 | 289 | 0.500 |
Why?
| | Mixed Connective Tissue Disease | 1 | 2015 | 10 | 0.490 |
Why?
| | Lupus Erythematosus, Discoid | 3 | 2022 | 8 | 0.470 |
Why?
| | Arthralgia | 2 | 2014 | 56 | 0.460 |
Why?
| | Mental Health | 3 | 2020 | 726 | 0.460 |
Why?
| | Lung Diseases | 1 | 2021 | 767 | 0.450 |
Why?
| | Program Evaluation | 1 | 2019 | 898 | 0.440 |
Why?
| | Antibodies, Antinuclear | 2 | 2019 | 71 | 0.410 |
Why?
| | Mycobacterium Infections | 1 | 2013 | 63 | 0.390 |
Why?
| | Arthritis | 1 | 2013 | 95 | 0.380 |
Why?
| | Shoes | 1 | 2012 | 18 | 0.380 |
Why?
| | Face | 1 | 2013 | 173 | 0.360 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2020 | 1329 | 0.350 |
Why?
| | Leg | 1 | 2012 | 236 | 0.330 |
Why?
| | Joint Instability | 1 | 2012 | 167 | 0.320 |
Why?
| | Mycobacterium tuberculosis | 1 | 2013 | 314 | 0.320 |
Why?
| | Child | 24 | 2025 | 21935 | 0.320 |
Why?
| | Myositis | 2 | 2025 | 52 | 0.320 |
Why?
| | Competency-Based Education | 4 | 2023 | 73 | 0.310 |
Why?
| | Anxiety | 1 | 2015 | 1035 | 0.290 |
Why?
| | Knee Joint | 1 | 2012 | 409 | 0.280 |
Why?
| | Humans | 47 | 2025 | 137585 | 0.280 |
Why?
| | Depression | 1 | 2015 | 1397 | 0.250 |
Why?
| | Risk Assessment | 1 | 2015 | 3457 | 0.250 |
Why?
| | Methotrexate | 2 | 2024 | 260 | 0.240 |
Why?
| | Psoriasis | 2 | 2024 | 102 | 0.240 |
Why?
| | Diagnosis, Differential | 4 | 2014 | 1483 | 0.230 |
Why?
| | Age of Onset | 3 | 2021 | 518 | 0.220 |
Why?
| | Consensus | 6 | 2024 | 683 | 0.210 |
Why?
| | Raynaud Disease | 1 | 2023 | 5 | 0.210 |
Why?
| | Stem Cell Transplantation | 1 | 2025 | 176 | 0.210 |
Why?
| | Patient Reported Outcome Measures | 2 | 2025 | 402 | 0.200 |
Why?
| | Edema | 2 | 2013 | 130 | 0.180 |
Why?
| | Needs Assessment | 1 | 2024 | 376 | 0.180 |
Why?
| | Female | 21 | 2025 | 73304 | 0.180 |
Why?
| | Reproducibility of Results | 4 | 2025 | 3284 | 0.170 |
Why?
| | Specialization | 1 | 2021 | 144 | 0.170 |
Why?
| | United States | 8 | 2025 | 14841 | 0.170 |
Why?
| | Purpura, Hyperglobulinemic | 1 | 2020 | 1 | 0.170 |
Why?
| | Trust | 1 | 2021 | 127 | 0.170 |
Why?
| | Purpura | 1 | 2020 | 17 | 0.170 |
Why?
| | Videoconferencing | 1 | 2020 | 66 | 0.170 |
Why?
| | Ultrasonography | 1 | 2024 | 759 | 0.160 |
Why?
| | Adalimumab | 1 | 2020 | 48 | 0.160 |
Why?
| | Ocular Motility Disorders | 1 | 2020 | 27 | 0.160 |
Why?
| | Dermatitis, Atopic | 1 | 2023 | 329 | 0.160 |
Why?
| | Extracellular Traps | 1 | 2020 | 53 | 0.160 |
Why?
| | Agammaglobulinemia | 1 | 2019 | 34 | 0.160 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2025 | 622 | 0.150 |
Why?
| | Physical Examination | 1 | 2020 | 241 | 0.150 |
Why?
| | Patient Simulation | 1 | 2019 | 37 | 0.150 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2015 | 3715 | 0.150 |
Why?
| | Rituximab | 1 | 2019 | 176 | 0.150 |
Why?
| | Vascular Diseases | 1 | 2021 | 243 | 0.150 |
Why?
| | Child Behavior | 1 | 2020 | 248 | 0.150 |
Why?
| | Adolescent | 13 | 2025 | 21513 | 0.140 |
Why?
| | Autoimmune Diseases | 2 | 2019 | 460 | 0.140 |
Why?
| | Dermatology | 1 | 2019 | 127 | 0.130 |
Why?
| | Professional Competence | 1 | 2018 | 100 | 0.130 |
Why?
| | Disability Evaluation | 1 | 2018 | 290 | 0.130 |
Why?
| | Antirheumatic Agents | 1 | 2019 | 293 | 0.130 |
Why?
| | Steroids | 2 | 2020 | 167 | 0.130 |
Why?
| | Parents | 2 | 2025 | 1347 | 0.120 |
Why?
| | Patient Care Planning | 1 | 2017 | 157 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 373 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 364 | 0.120 |
Why?
| | Adolescent Behavior | 1 | 2020 | 530 | 0.120 |
Why?
| | Internet | 1 | 2020 | 655 | 0.120 |
Why?
| | Lung Diseases, Interstitial | 1 | 2021 | 638 | 0.110 |
Why?
| | Membrane Proteins | 1 | 2021 | 1164 | 0.110 |
Why?
| | Practice Guidelines as Topic | 3 | 2025 | 1587 | 0.110 |
Why?
| | Neutrophils | 1 | 2020 | 1238 | 0.110 |
Why?
| | Endocrinology | 2 | 2021 | 79 | 0.110 |
Why?
| | Certification | 2 | 2025 | 113 | 0.110 |
Why?
| | Laryngeal Diseases | 1 | 2013 | 31 | 0.100 |
Why?
| | Surveys and Questionnaires | 5 | 2025 | 5778 | 0.100 |
Why?
| | Hypothyroidism | 1 | 2013 | 72 | 0.100 |
Why?
| | Myocarditis | 1 | 2014 | 100 | 0.100 |
Why?
| | Male | 15 | 2025 | 67762 | 0.100 |
Why?
| | Arthritis, Reactive | 1 | 2012 | 8 | 0.100 |
Why?
| | Stress, Psychological | 1 | 2020 | 1100 | 0.100 |
Why?
| | Patellofemoral Joint | 1 | 2012 | 9 | 0.100 |
Why?
| | Synovial Fluid | 1 | 2012 | 68 | 0.090 |
Why?
| | Flatfoot | 1 | 2012 | 13 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1639 | 0.090 |
Why?
| | Telemedicine | 1 | 2020 | 862 | 0.090 |
Why?
| | Eosinophilia | 1 | 2014 | 218 | 0.090 |
Why?
| | Dyspnea | 1 | 2013 | 254 | 0.090 |
Why?
| | Gestational Age | 1 | 2014 | 910 | 0.090 |
Why?
| | Arthritis, Infectious | 1 | 2012 | 69 | 0.090 |
Why?
| | Sarcoidosis | 1 | 2013 | 159 | 0.090 |
Why?
| | North America | 2 | 2024 | 313 | 0.090 |
Why?
| | Delphi Technique | 2 | 2025 | 280 | 0.080 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2014 | 385 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 1 | 2019 | 1313 | 0.080 |
Why?
| | Evoked Potentials, Auditory | 1 | 2011 | 180 | 0.080 |
Why?
| | Child Development | 1 | 2014 | 475 | 0.080 |
Why?
| | Speech Perception | 1 | 2011 | 82 | 0.080 |
Why?
| | Patient Selection | 2 | 2025 | 696 | 0.080 |
Why?
| | Neuropsychological Tests | 1 | 2013 | 1023 | 0.070 |
Why?
| | Disorders of Sex Development | 1 | 2008 | 39 | 0.070 |
Why?
| | Cerebral Cortex | 1 | 2011 | 433 | 0.070 |
Why?
| | Cost of Illness | 2 | 2020 | 308 | 0.070 |
Why?
| | Learning | 1 | 2011 | 409 | 0.060 |
Why?
| | Pain | 1 | 2012 | 756 | 0.060 |
Why?
| | Quality of Life | 3 | 2025 | 2892 | 0.060 |
Why?
| | Registries | 3 | 2020 | 2035 | 0.060 |
Why?
| | Child, Preschool | 5 | 2024 | 11074 | 0.060 |
Why?
| | Time Factors | 3 | 2025 | 6828 | 0.060 |
Why?
| | Transplantation, Autologous | 1 | 2025 | 238 | 0.050 |
Why?
| | Dermatitis | 1 | 2024 | 20 | 0.050 |
Why?
| | Infant | 3 | 2014 | 9465 | 0.050 |
Why?
| | Acne Vulgaris | 1 | 2024 | 29 | 0.050 |
Why?
| | Scleroderma, Localized | 1 | 2023 | 10 | 0.050 |
Why?
| | Skin Ulcer | 1 | 2023 | 14 | 0.050 |
Why?
| | Social Support | 1 | 2008 | 618 | 0.050 |
Why?
| | Accreditation | 1 | 2023 | 83 | 0.050 |
Why?
| | Dermatologic Agents | 1 | 2024 | 70 | 0.050 |
Why?
| | Brain | 1 | 2014 | 2668 | 0.050 |
Why?
| | Neurons | 1 | 2011 | 1590 | 0.050 |
Why?
| | Administrative Personnel | 1 | 2021 | 29 | 0.050 |
Why?
| | Infectious Disease Medicine | 1 | 2021 | 13 | 0.050 |
Why?
| | Nocardia Infections | 1 | 2021 | 9 | 0.050 |
Why?
| | Patient Handoff | 1 | 2021 | 32 | 0.040 |
Why?
| | Retrospective Studies | 4 | 2022 | 15657 | 0.040 |
Why?
| | Hematology | 1 | 2021 | 20 | 0.040 |
Why?
| | Pediatric Emergency Medicine | 1 | 2021 | 24 | 0.040 |
Why?
| | Gain of Function Mutation | 1 | 2021 | 36 | 0.040 |
Why?
| | Adolescent Medicine | 1 | 2021 | 30 | 0.040 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 1 | 2021 | 36 | 0.040 |
Why?
| | Neonatology | 1 | 2021 | 29 | 0.040 |
Why?
| | Psychometrics | 1 | 2025 | 720 | 0.040 |
Why?
| | Pulmonary Medicine | 1 | 2021 | 85 | 0.040 |
Why?
| | Language | 1 | 2023 | 292 | 0.040 |
Why?
| | Multiple Organ Failure | 1 | 2021 | 128 | 0.040 |
Why?
| | Fatal Outcome | 1 | 2021 | 303 | 0.040 |
Why?
| | Self Report | 1 | 2025 | 827 | 0.040 |
Why?
| | Family Relations | 1 | 2020 | 91 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5472 | 0.040 |
Why?
| | Dermatologists | 1 | 2019 | 6 | 0.040 |
Why?
| | Europe | 1 | 2020 | 414 | 0.040 |
Why?
| | Adult | 5 | 2025 | 37929 | 0.040 |
Why?
| | Medicine | 1 | 2021 | 121 | 0.040 |
Why?
| | Rheumatologists | 1 | 2019 | 16 | 0.040 |
Why?
| | Disease Progression | 2 | 2019 | 2757 | 0.040 |
Why?
| | Linear Models | 1 | 2021 | 849 | 0.040 |
Why?
| | Gastroenterology | 1 | 2021 | 180 | 0.040 |
Why?
| | Medical Oncology | 1 | 2021 | 289 | 0.040 |
Why?
| | Resilience, Psychological | 1 | 2020 | 128 | 0.040 |
Why?
| | Depression, Postpartum | 1 | 2000 | 132 | 0.040 |
Why?
| | Sleep Deprivation | 1 | 2000 | 174 | 0.040 |
Why?
| | Cohort Studies | 2 | 2022 | 5742 | 0.040 |
Why?
| | Focus Groups | 1 | 2020 | 522 | 0.040 |
Why?
| | Bipolar Disorder | 1 | 2000 | 263 | 0.030 |
Why?
| | Betacoronavirus | 1 | 2020 | 270 | 0.030 |
Why?
| | Curriculum | 1 | 2024 | 992 | 0.030 |
Why?
| | Phenotype | 2 | 2017 | 3196 | 0.030 |
Why?
| | Consensus Development Conferences as Topic | 1 | 2017 | 31 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2019 | 889 | 0.030 |
Why?
| | Infant, Newborn | 3 | 2015 | 6079 | 0.030 |
Why?
| | Depressive Disorder, Major | 1 | 2000 | 364 | 0.030 |
Why?
| | Anti-Inflammatory Agents | 1 | 2020 | 496 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2021 | 786 | 0.030 |
Why?
| | Adaptation, Psychological | 1 | 2020 | 655 | 0.030 |
Why?
| | Qualitative Research | 1 | 2022 | 1386 | 0.030 |
Why?
| | Panniculitis, Lupus Erythematosus | 1 | 2015 | 1 | 0.030 |
Why?
| | Oral Ulcer | 1 | 2015 | 10 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2019 | 893 | 0.030 |
Why?
| | Caudate Nucleus | 1 | 2014 | 23 | 0.030 |
Why?
| | Putamen | 1 | 2014 | 23 | 0.030 |
Why?
| | Risk Factors | 2 | 2019 | 10388 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1710 | 0.030 |
Why?
| | Lupus Nephritis | 1 | 2015 | 63 | 0.030 |
Why?
| | Globus Pallidus | 1 | 2014 | 26 | 0.030 |
Why?
| | Lateral Ventricles | 1 | 2014 | 35 | 0.030 |
Why?
| | Hypereosinophilic Syndrome | 1 | 2014 | 11 | 0.030 |
Why?
| | Brain Stem | 1 | 2014 | 94 | 0.030 |
Why?
| | Organ Size | 1 | 2014 | 477 | 0.030 |
Why?
| | Thalamus | 1 | 2014 | 107 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2020 | 951 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 2031 | 0.030 |
Why?
| | Amygdala | 1 | 2014 | 191 | 0.030 |
Why?
| | Age Factors | 1 | 2020 | 3295 | 0.030 |
Why?
| | Rheumatic Diseases | 1 | 2014 | 81 | 0.030 |
Why?
| | Cerebellum | 1 | 2014 | 224 | 0.020 |
Why?
| | Societies, Medical | 1 | 2017 | 820 | 0.020 |
Why?
| | Prevalence | 1 | 2019 | 2734 | 0.020 |
Why?
| | Hip Joint | 1 | 2014 | 171 | 0.020 |
Why?
| | Physical Exertion | 1 | 2013 | 215 | 0.020 |
Why?
| | Reaction Time | 1 | 2013 | 412 | 0.020 |
Why?
| | Language Tests | 1 | 2011 | 23 | 0.020 |
Why?
| | Vocabulary | 1 | 2011 | 38 | 0.020 |
Why?
| | Mass Screening | 1 | 2019 | 1287 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 2 | 2014 | 3566 | 0.020 |
Why?
| | Heart Diseases | 1 | 2014 | 346 | 0.020 |
Why?
| | Biomedical Research | 1 | 2017 | 692 | 0.020 |
Why?
| | Magnetoencephalography | 1 | 2011 | 149 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2014 | 752 | 0.020 |
Why?
| | Skin | 1 | 2015 | 752 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 4030 | 0.020 |
Why?
| | Thrombosis | 1 | 2014 | 371 | 0.020 |
Why?
| | Hippocampus | 1 | 2014 | 895 | 0.020 |
Why?
| | Brain Mapping | 1 | 2011 | 503 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2012 | 740 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2057 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2014 | 2844 | 0.020 |
Why?
| | Autoantibodies | 1 | 2015 | 1496 | 0.020 |
Why?
| | Kidney | 1 | 2015 | 1468 | 0.020 |
Why?
| | Prospective Studies | 1 | 2018 | 7604 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2013 | 3556 | 0.010 |
Why?
| | Young Adult | 1 | 2020 | 13209 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2013 | 5131 | 0.010 |
Why?
| | Treatment Outcome | 2 | 2012 | 10811 | 0.010 |
Why?
| | Obesity | 1 | 2013 | 2992 | 0.010 |
Why?
| | Circadian Rhythm | 1 | 2000 | 468 | 0.010 |
Why?
| | Pregnancy | 1 | 2000 | 6763 | 0.000 |
Why?
|
|
Curran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|